Cargando…
Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity
The glutamate-aspartate transporter GLAST is a radial glia marker that is highly expressed in GL261 stem-like cells (GSCs). To target GLAST, we treated glioma-bearing mice with three subcutaneous injections of four GLAST peptides emulsified with Montanide ISA-51 in association with granulocyte macro...
Autores principales: | Cantini, Gabriele, Pisati, Federica, Pessina, Sara, Finocchiaro, Gaetano, Pellegatta, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489744/ https://www.ncbi.nlm.nih.gov/pubmed/23162756 http://dx.doi.org/10.4161/onci.20637 |
Ejemplares similares
-
The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma
por: Pessina, Sara, et al.
Publicado: (2015) -
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
por: Frattini, Véronique, et al.
Publicado: (2012) -
A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells
por: De Rosa, Antonella, et al.
Publicado: (2012) -
ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019) -
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)